- Report
- September 2026
- 189 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- September 2026
- 386 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- May 2026
- 180 Pages
Global
From €4090EUR$4,500USD£3,517GBP
- Report
- August 2026
- 160 Pages
Global
From €3018EUR$3,320USD£2,595GBP
€3772EUR$4,150USD£3,243GBP
- Report
- November 2025
- 150 Pages
Global
From €4409EUR$4,850USD£3,790GBP
- Report
- September 2026
- 186 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- September 2026
- 185 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- September 2026
- 365 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- July 2026
- 200 Pages
Global
From €7263EUR$7,990USD£6,245GBP
- Report
- July 2026
- 200 Pages
Global
From €7263EUR$7,990USD£6,245GBP
- Report
- May 2026
- 350 Pages
Global
From €4499EUR$4,949USD£3,868GBP
- Report
- May 2026
- 152 Pages
Global
From €3590EUR$3,950USD£3,087GBP
- Report
- May 2026
- 152 Pages
Global
From €3590EUR$3,950USD£3,087GBP
- Report
- October 2025
- 150 Pages
Global
From €4409EUR$4,850USD£3,790GBP
- Report
- October 2025
- 163 Pages
Global
From €3500EUR$4,125USD£3,115GBP
- Report
- July 2022
- 165 Pages
Global
From €5408EUR$5,950USD£4,650GBP
- Report
- November 2023
- 90 Pages
France
From €3181EUR$3,500USD£2,735GBP
- Report
- August 2024
- 82 Pages
Japan
From €3181EUR$3,500USD£2,735GBP

Cellular Immunotherapy is a type of Immune Disorders Drugs that uses a patient's own immune cells to treat diseases. It is a form of personalized medicine that is tailored to the individual patient's needs. It works by stimulating the patient's own immune system to recognize and attack cancer cells or other diseased cells. It can also be used to treat autoimmune diseases, such as rheumatoid arthritis, lupus, and multiple sclerosis.
Cellular Immunotherapy is a rapidly growing field, with many companies developing new treatments and technologies. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing new treatments for immune disorders. Other companies, such as Celgene, are also researching and developing new treatments for immune disorders. Additionally, many universities and research institutions are conducting research into the potential of Cellular Immunotherapy. Show Less Read more